HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Bingliang Fang Selected Research
Bingliang Fang Research Topics
Disease
103
Neoplasms (Cancer)
01/2022 - 03/2002
43
Lung Neoplasms (Lung Cancer)
01/2022 - 10/2003
28
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 04/2004
14
Colonic Neoplasms (Colon Cancer)
01/2019 - 03/2002
7
Carcinogenesis
01/2021 - 06/2006
5
Neoplasm Metastasis (Metastasis)
01/2021 - 05/2002
5
Breast Neoplasms (Breast Cancer)
01/2013 - 11/2002
4
Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 07/2005
4
Hypoxia (Hypoxemia)
01/2021 - 03/2006
4
Glioma (Gliomas)
10/2011 - 01/2002
3
B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 08/2017
3
Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 08/2003
3
Adenocarcinoma
08/2019 - 04/2006
3
Leukemia
11/2017 - 01/2015
3
Carcinoma (Carcinomatosis)
01/2013 - 09/2004
3
Infections
11/2009 - 12/2002
3
Prostatic Neoplasms (Prostate Cancer)
05/2008 - 03/2002
3
Ovarian Neoplasms (Ovarian Cancer)
07/2005 - 12/2002
2
Lymphoma (Lymphomas)
01/2022 - 01/2021
2
Aneuploidy (Aneuploid)
01/2021 - 01/2019
2
COVID-19
01/2020 - 01/2020
2
Rheumatoid Arthritis
10/2018 - 01/2016
2
Glioblastoma (Glioblastoma Multiforme)
07/2011 - 11/2009
2
Kidney Neoplasms (Kidney Cancer)
01/2011 - 04/2010
2
Virus Diseases (Viral Diseases)
09/2008 - 06/2006
Drug/Important Bio-Agent (IBA)
27
Proteins (Proteins, Gene)
FDA Link
11/2021 - 07/2002
14
Biomarkers (Surrogate Marker)
IBA
01/2022 - 06/2009
14
Antineoplastic Agents (Antineoplastics)
IBA
01/2021 - 02/2004
13
Telomerase (Telomerase Reverse Transcriptase)
IBA
11/2012 - 07/2002
11
Pharmaceutical Preparations
IBA
01/2019 - 03/2008
10
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2017 - 03/2002
10
Ligands
IBA
01/2017 - 03/2002
8
Small Interfering RNA (siRNA)
IBA
01/2013 - 08/2003
7
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2022 - 11/2009
7
ErbB Receptors (EGF Receptor)
IBA
01/2021 - 05/2008
6
Phosphotransferases (Kinase)
IBA
01/2019 - 03/2004
6
Enzymes
IBA
01/2019 - 08/2002
6
1- ((3- chlorophenyl)methyl)- 1H- indole- 3- carbinol
IBA
11/2017 - 01/2011
5
AZD 6244
IBA
01/2022 - 11/2009
5
eIF-2 Kinase (eIF 2 Kinase)
IBA
01/2020 - 11/2010
5
Auranofin (Ridaura)
FDA Link
11/2019 - 01/2016
5
Paclitaxel (Taxol)
FDA Link
Generic
12/2013 - 09/2003
4
TNF-Related Apoptosis-Inducing Ligand
IBA
01/2019 - 11/2002
4
ibrutinib
IBA
10/2018 - 08/2013
4
NSC-741909
IBA
01/2011 - 06/2009
4
Caspase 3 (Caspase-3)
IBA
05/2008 - 02/2004
4
Caspases
IBA
07/2005 - 06/2002
3
Antibodies
IBA
01/2022 - 03/2013
3
Cyclin D1
IBA
08/2019 - 09/2009
3
Caspase 8 (Caspase-8)
IBA
01/2019 - 02/2004
3
Messenger RNA (mRNA)
IBA
11/2016 - 09/2009
3
MK 2206
IBA
09/2013 - 11/2010
3
oncrasin-1
IBA
04/2011 - 09/2008
3
ras Proteins
IBA
02/2009 - 08/2003
3
Green Fluorescent Proteins
IBA
09/2006 - 07/2002
3
Bortezomib (Velcade)
FDA Link
06/2006 - 07/2005
3
Proteasome Inhibitors
IBA
06/2006 - 07/2005
3
Member 1 Subfamily B ATP Binding Cassette Transporter
IBA
03/2006 - 07/2005
3
Gemcitabine
FDA Link
12/2005 - 09/2003
3
Cytochromes c (Cytochrome c)
IBA
07/2005 - 02/2004
2
Indicators and Reagents (Reagents)
IBA
01/2022 - 01/2013
2
Mitogen-Activated Protein Kinases
IBA
01/2022 - 03/2005
2
Dihydroorotate Dehydrogenase
IBA
08/2021 - 01/2021
2
Cystine (L-Cystine)
IBA
06/2021 - 01/2020
2
Glucose (Dextrose)
FDA Link
Generic
06/2021 - 01/2020
2
Disulfides
IBA
06/2021 - 01/2020
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2021 - 03/2006
2
Aspartic Acid (Aspartate)
FDA Link
01/2021 - 02/2005
2
RNA (Ribonucleic Acid)
IBA
01/2020 - 08/2003
2
Cysteine (L-Cysteine)
FDA Link
01/2020 - 04/2010
2
Glutathione (Reduced Glutathione)
IBA
01/2019 - 01/2019
2
Thioredoxin-Disulfide Reductase
IBA
01/2019 - 01/2019
2
Antigens
IBA
01/2019 - 11/2007
2
Tyrosine Kinase Inhibitors
IBA
12/2018 - 05/2015
2
Gold
IBA
10/2018 - 01/2016
2
DNA (Deoxyribonucleic Acid)
IBA
01/2018 - 04/2006
2
Erlotinib Hydrochloride (CP 358,774)
FDA Link
11/2016 - 09/2014
2
Methanol (Carbinol)
IBA
10/2016 - 12/2010
2
Sorafenib (BAY 43-9006)
FDA Link
01/2016 - 06/2006
2
Agammaglobulinaemia Tyrosine Kinase
IBA
09/2014 - 08/2013
2
STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)
IBA
03/2014 - 05/2012
2
Insulin-Like Peptides
IBA
12/2013 - 01/2013
2
Catenins
IBA
12/2013 - 07/2011
2
matrigel
IBA
11/2012 - 04/2010
2
RNA Polymerase II (RNA Polymerase B)
IBA
04/2011 - 01/2011
2
indole
IBA
12/2010 - 02/2009
2
X-Linked Inhibitor of Apoptosis Protein
IBA
05/2008 - 05/2008
2
Death Domain Receptors
IBA
04/2007 - 04/2005
2
Caspase 9
IBA
07/2005 - 02/2004
2
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
07/2005 - 02/2004
2
bcl-2-Associated X Protein (bcl 2 Associated X Protein)
IBA
06/2005 - 04/2004
2
Fluorouracil (Carac)
FDA Link
Generic
03/2005 - 05/2004
2
2- ((3- (2,3- dichlorophenoxy)propyl)amino)ethanol
IBA
06/2004 - 02/2004
Therapy/Procedure
41
Therapeutics
01/2022 - 11/2002
6
Radiotherapy
01/2019 - 10/2003
5
Immunotherapy
01/2019 - 11/2007
4
Drug Therapy (Chemotherapy)
09/2008 - 09/2003
3
Aftercare (After-Treatment)
01/2021 - 06/2009
2
Precision Medicine
01/2016 - 07/2015
2
Injections
04/2006 - 09/2005